CDER’s 14 Approvals In The First Half Of 2016
Executive Summary
Interactive table shows the new molecular entity and novel therapeutic biologics approved by FDA in the first half of 2016.
Click here for a full-screen view of the CDER first half 2016 approvals chart
NME And Novel Therapeutic Biologic Approvals